Literature DB >> 20732409

Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss.

Yasmine A Gomaa1, Desmond I J Morrow, Martin J Garland, Ryan F Donnelly, Labiba K El-Khordagui, Victor M Meidan.   

Abstract

Microneedle (MN) arrays have attracted considerable attention in recent years due to their ability to facilitate effective transdermal drug delivery. Despite appreciable research, there is still debate about how different MN dimensions or application modes influence permeabilization. This study aimed to investigate this issue by taking transepidermal water-loss measurements of dermatomed human skin samples following the insertion of solid polymeric MNs. Insertions caused an initial sharp drop in barrier function followed by a slower incomplete recovery - a paradigm consistent with MN-generation of microchannels that subsequently contract due to skin elasticity. While 600 μm-long MNs were more skin-perturbing than 400 μm MNs, insertion of 1000 μm-long MNs caused a smaller initial drop in integrity followed by a degree of long term permeabilization. This is explainable by the longest needles compacting the tissue, which then decompresses over subsequent hours. Multiple insertions had a similar effect as increasing MN length. There was some evidence that increasing MN density suppressed the partial barrier recovery caused by tissue contraction. Leaving MNs embedded in skin seemed to reduce the initial post-insertion drop in barrier function. Our results suggest that this in vitro TEWL approach can be used to rapidly screen MN-effects on skin.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732409     DOI: 10.1016/j.tiv.2010.08.012

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  31 in total

1.  Skin drug permeability and safety through a vibrating solid micro-needle system.

Authors:  Ting-Ting Liu; Kai Chen; Qiao Wang
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Enhanced skin delivery of vismodegib by microneedle treatment.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

Review 3.  Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.

Authors:  Rebecca E M Lutton; Jessica Moore; Eneko Larrañeta; Stephen Ligett; A David Woolfson; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

4.  Fractional thermolysis by bipolar radiofrequency facilitates cutaneous delivery of peptide and siRNA with minor loss of barrier function.

Authors:  Woan-Ruoh Lee; Shing-Chuan Shen; Chi-Kuang Sun; Ibrahim A Aljuffali; Shih-Yun Suen; Yin-Ku Lin; Jhi-Joung Wang; Jia-You Fang
Journal:  Pharm Res       Date:  2014-11-13       Impact factor: 4.200

5.  Effect of microneedles on transdermal permeation enhancement of amlodipine.

Authors:  Buchi N Nalluri; Chandrateja Uppuluri; Jyothirmayee Devineni; Atul Nayak; Karthik J Nair; Benjamin R Whiteside; Diganta B Das
Journal:  Drug Deliv Transl Res       Date:  2017-02-03       Impact factor: 4.617

6.  Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet.

Authors:  Ryan F Donnelly; Kurtis Moffatt; Ahlam Zaid Alkilani; Eva M Vicente-Pérez; Johanne Barry; Maelíosa T C McCrudden; A David Woolfson
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

7.  Flux of ionic dyes across microneedle-treated skin: effect of molecular characteristics.

Authors:  Yasmine A Gomaa; Martin J Garland; Fiona J McInnes; Ryan F Donnelly; Labiba K El-Khordagui; Clive G Wilson
Journal:  Int J Pharm       Date:  2012-08-30       Impact factor: 5.875

8.  Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.

Authors:  Priyanka Ghosh; Nicole K Brogden; Audra L Stinchcomb
Journal:  Mol Pharm       Date:  2013-05-13       Impact factor: 4.939

9.  Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium.

Authors:  Yasmine A Gomaa; Martin J Garland; Fiona McInnes; Labiba K El-Khordagui; Clive Wilson; Ryan F Donnelly
Journal:  Eur J Pharm Biopharm       Date:  2012-07-23       Impact factor: 5.571

10.  Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye.

Authors:  Yasmine A Gomaa; Labiba K El-Khordagui; Martin J Garland; Ryan F Donnelly; Fiona McInnes; Victor M Meidan
Journal:  J Pharm Pharmacol       Date:  2012-07-09       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.